Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone versus placebo for coronary plaque composition in non-diabetic coronary heart disease
2006-000186-11Phase 2Completed
- Sponsor
- MedKlinik
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in coronary arteriosclerosis comparing Pioglitazone with Placebo (2 arms). Primary endpoint: Change in percentage of fatty and necrotic plaque components. Started Sep 2006; status: completed.
02
Drugs
pioglitazone
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2006-000186-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000186-11.